Cargando…

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice

Highly purified populations of L3T4+ and Lyt-2+ T cell subsets were compared for their capacity to cause lethal GVHD in six different H-2- compatible, multiple minor histocompatibility antigen-different murine strain combinations. In four of these combinations (C3H.SW----B6, DBA/2- ---B10.D2, B10.BR...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1987
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188361/ https://www.ncbi.nlm.nih.gov/pubmed/3108446

Ejemplares similares

Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex
Publicado: (1980)

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers
Publicado: (1982)

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow
Publicado: (1978)

AN ASSAY OF GRAFT-HOST INTERACTIONS ACROSS STRONG AND WEAK HISTOCOMPATIBILITY BARRIERS IN MICE
por: Miller, Joshua, et al.
Publicado: (1963)

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
por: Olsen, Kelly S., et al.
Publicado: (2022)

Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones
Publicado: (1990)

P65. Minor-histocompatibility-antigen UTY as target for graft-versus-leukaemia and graft-versus-haematopoiesis in the canine-model
por: Bund, D, et al.
Publicado: (2014)

Capacity of genetically different T lymphocytes to induce lethal graft- versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft- versus-host disease
Publicado: (1981)

Does minor histocompatibility antigen HA‐1 disparity affect the occurrence of graft‐versus‐host disease in tunisian recipients of hematopoietic stem cells?
por: Sellami, Mohamed Hichem, et al.
Publicado: (2010)

Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin
Publicado: (1982)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
por: Choi, Eun Young, et al.
Publicado: (2020)

Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones
Publicado: (1991)

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation
por: Petersdorf, Effie W.
Publicado: (2017)

Minor Histocompatibility Antigen-Specific T Cells
por: Summers, Corinne, et al.
Publicado: (2020)

Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA- B35 subtype molecules
Publicado: (1995)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens
Publicado: (1975)

The Effects of Anthrax Lethal Toxin on Host Barrier Function
por: Xie, Tao, et al.
Publicado: (2011)

Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions
Publicado: (1993)

Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease
por: Novota, Peter, et al.
Publicado: (2011)

Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation
por: Gezinir, Emin, et al.
Publicado: (2020)

Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity
por: Grayson, Jason M., et al.
Publicado: (2020)

Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens
Publicado: (1984)

The Human Minor Histocompatibility Antigen1 Is a RhoGAP
por: de Kreuk, Bart-Jan, et al.
Publicado: (2013)

Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation
por: Yu, Dongdong, et al.
Publicado: (2019)

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
Publicado: (1996)

Atopic Dermatitis-like Graft-versus-host Disease and Lichen Planus-like Graft-versus-host Disease: Alterations in Skin Barrier Function and Related Molecules
por: Li, Kun, et al.
Publicado: (2017)

Lithothamnion muelleri Controls Inflammatory Responses, Target Organ Injury and Lethality Associated with Graft-versus-Host Disease in Mice
por: Rezende, Barbara M., et al.
Publicado: (2013)

T cells recognize minor histocompatibility antigens on H-2 allogeneic cells
Publicado: (1979)

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
por: Martin, Paul J., et al.
Publicado: (2021)

Minor histocompatibility antigens HA‐8 and PANE1 in the TUNISIAN population
por: Said, Rahma, et al.
Publicado: (2022)

GRAFT-VERSUS-HOST REACTION ACROSS DIFFERENT REGIONS OF THE H-2 COMPLEX OF THE MOUSE
por: Klein, Jan, et al.
Publicado: (1973)

Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde- treated cells: evidence for antigen processing
Publicado: (1980)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project
por: Bykova, Nadia A., et al.
Publicado: (2018)

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
por: Akatsuka, Yoshiki
Publicado: (2020)

Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis
por: Zong, Rui-Qing, et al.
Publicado: (2022)

Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease
por: Steinbach, Gideon, et al.
Publicado: (2017)

Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects
por: Bernardes, Priscila T. T., et al.
Publicado: (2015)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_fh3prbrbbsdjqhgvmeu1a9k9jg